Lilla MC Roy

Lilla MC Roy

Auto-generated profile, based on publicly available information

Lilla MC Roy

School of Public Health, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NONathan N. O’hara
Nathan N. O’hara
LRLilla Roy
Lilla Roy
LOLyndsay M. O’hara
Lyndsay M. O’hara
JSJerry M. Spiegel
Jerry M. Spiegel
LLLarry D. Lynd
Larry D. Lynd
CMCarlo A. Marra
Carlo A. Marra
Healthcare workers (HCWs) in South Africa are at a high risk of developing active tuberculosis (TB) due to their occupational exposures. This study aimed to systematically quantify and compare the preferred attributes of an active TB case finding program for HCWs in South Africa. A Best–Worst Scaling choice experiment estimated HCW’s preferences using a random-effects conditional logit model. Latent class analysis (LCA) was used to explore heterogeneity in preferences. “No cost”, “the assurance of confidentiality”, “no wait” and testing at the occupational health unit at one’s hospital were the most preferred attributes. LCA identified a four class model with consistent differences in preference strength. Sex, occupation, and the time since a previous TB test were statistically significant predictors of class membership. The findings support the strengthening of occupational health units in South Africa to offer free and confidential active TB case finding programs for HCWs with minimal wait times. There is considerable variation in active TB case finding preferences amongst HCWs of different gender, occupation, and testing history. Attention to heterogeneity in preferences should optimize screening utilization of target HCW populations.

24 May 2016 in The Pharmacogenomics Journal
Verified
Journal Article
Closed access
PDF file
RZR M Zur
R M Zur
LRL M Roy
L M Roy
SIS Ito
S Ito
JBJ Beyene
J Beyene
CCC Carew
C Carew
WUWendy J. Ungar
Wendy J. Ungar

29 March 2016 in Pharmacogenomics
Verified
Journal Article
Closed access
LRLilla M Roy
Lilla M Roy
RZRichard M Zur
Richard M Zur
EUElizabeth Uleryk
Elizabeth Uleryk
CCChris Carew
Chris Carew
SIShinya Ito
Shinya Ito
WUWendy J. Ungar
Wendy J. Ungar
Aim: Thiopurine S-methyltransferase (TPMT) testing is used in patients receiving thiopurines to identify enzyme deficiencies and risk for adverse drug reactions. It is uncertain whether genotyping is superior to phenotyping. The objectives were to conduct a systematic review of TPMT-test performance studies. Materials & methods: Electronic and grey literature sources were searched for studies reporting test performance compared with a reference standard. Sixty-six eligible studies were appraised for quality. Results: Thirty phenotype–genotype and six phenotype–phenotype comparisons were of high quality. The calculated sensitivity and specificity for genotyping to identify a homozygous mutation ranged from 0.0–100.0% and from 97.8–100.0%, respectively. Conclusion: Clinical decision-makers require high-quality evidence of clinical validity and clinical utility of TPMT genotyping to ensure appropriate use in patients.

3 March 2014 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
LRLilla MC Roy
Lilla MC Roy
NBNick Bansback
Nick Bansback
CMCarlo Marra
Carlo Marra
RCRoxane Carr
Roxane Carr
MCMark Chilvers
Mark Chilvers
LLLarry D Lynd
Larry D Lynd

16 September 2023 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
LRLilla M. Roy
Lilla M. Roy
ANAidan Neill
Aidan Neill
KSKristen Swampy
Kristen Swampy
JAJuliette Auger
Juliette Auger
SCSandra M Campbell
Sandra M Campbell
JJJeffrey A. Johnson
Jeffrey A. Johnson
Purpose: In many countries, there are calls to address health inequalities experienced by Indigenous people. Preference-based measures (PBMs) provide a measurement of health-related quality of life and can support resource allocation decisions. This review aimed to identify, summarize, and appraise the literature reporting the use and performance of PBMs with Indigenous people. Methods: Eleven major databases were searched from inception to August 31, 2022. Records in English that (1) assessed any measurement property of PBMs, (2) directly elicited health preferences, (3) reported the development or translation of PBMs for Indigenous people, or (4) measured health-related quality of life (HRQL) using PBMs were included. Ethically engaged research with Indigenous people was considered as an element of methodological quality. Data was synthesized descriptively (PROSPERO ID: CRD42020205239). Results: Of 3139 records identified, 81 were eligible, describing psychometric evaluation (n = 4), preference elicitation (n = 4), development (n = 4), translation (n = 2), and HRQL measurement (n = 71). 31 reported ethically engaged research. Reports originated primarily from Australia (n = 38), New Zealand (n = 20), USA (n = 9) and Canada (n = 6). Nearly all (n = 73) reported indirect, multi-attribute PBMs, the most common of which was the EQ-5D (n = 50). Conclusion: A large number of recent publications from diverse disciplines report the use of PBMs with Indigenous people, despite little evidence on measurement properties in these populations. Understanding the measurement properties of PBMs with Indigenous people is important to better understand how these measures might, or might not, be used in policy and resource decisions affecting Indigenous people. (Funding: EuroQoL Research Foundation).

Verified
Other
Open access
PDF file
LRLilla MC Roy
Lilla MC Roy
Background: RSV infects the majority of infants under one year, and is a leading cause of bronchiolitis-related hospitalization, incurring significant cost on the health care system. Economic evaluation guidelines require the use of quality-adjusted life years (QALYs) – a single measure of health outcome that incorporates both quality of life and length of life; however, there is no established standard for eliciting health utilities in children. Measuring utility in infant RSV presents significant methodological challenges related to proxy response, perspective of the elicitation task, and the temporary nature of the health condition combined with potential long-term outcomes. Objectives: The objectives of this thesis were to: 1) review the methodological literature surrounding infant utility derivation using a proxy respondent and in temporary health states; 2) derive the health utility for different severities of Respiratory Syncytial Virus (RSV) infection; and 3) determine relative preferences of health state attributes for RSV in infants. Methods: Using results from a literature review and qualitative study, time trade-off (TTO) and best-worst scaling (BWS) experiments were constructed reflecting four RSV severity levels, using two perspectives – child and adult. Administered online, respondents randomly received either a questionnaire from either the adult or child perspective, completing both TTO and BWS tasks, allowing elicitation and comparison of both health state utilities and relative preferences for health state attributes from two perspectives Results: Respondents were willing to trade off more time to avoid more severe health states, indicating greater disutility associated with severe RSV, and suggests respondents understood the task. Responses differed between the adult and child perspectives, with disutilities from the child perspective being slightly greater. BWS revealed that respondents most often chose breathing failure as the worst attribute and 0% risk of wheeze as the best from both perspectives. Conclusion: Responses differ between adult and child perspectives. This is the first study known to explore utilities for RSV in infants, and can be utilized for the further utility research and economic evaluation of any current or potential treatment for RSV, or other temporary health states in infants.